Advertisement

P011Impact of texas’ 2020 executive order on abortion access and wait times

      This paper is only available as a PDF. To read, Please Download here.

      Objectives

      In March 2020, Texas issued an executive order prohibiting most abortions for a 30-day period (March 22, 2020–April 21, 2020). We assess whether patients who attended the state-mandated ultrasound visit during this period returned for their abortion and the interval between visits among those who returned compared with a 2019 cohort.

      Methods

      We collected individual-level data on ultrasound and abortion visits from February to May 2019 (2019 cohort) and February to May 2020 (2020 cohort) at 13 Texas facilities. We used logistic regression to assess changes in the proportion of patients who had an ultrasound during the executive order and returned for their abortion compared with the same 30-day period in 2019. We used linear regression to assess changes in the interval between ultrasound and abortion visits between the two time periods.

      Results

      Of the 1,640 patients in the 2020 cohort, 1,358 (83%) returned for their abortion compared with 2,987 of the 3,304 (90%) in the 2019 cohort (p<0.001). Of the 1,358 who returned in the 2020 cohort, 813 (60%) got their abortion within the 30-day executive order period compared with 2,621 of the 2,884 (88%) in the 2019 cohort (OR, 0.44; 95% CI, 0.34–0.56). Median wait times for the 2020 cohort were longest for patients who had a procedural abortion vs. a medication abortion (Coefficient, 9.55; 95% CI, 8.21–10.89) and increased from two days (IQR, 1–5) in 2019 to nine days (IQR, 6–15) in 2020 (Coefficient, 0.91; 95% CI, 0.49–1.34).

      Conclusions

      Fewer patients returned for their abortion in 2020 and those not eligible for medication abortion had longer wait times.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect